中国实用医药2024,Vol.19Issue(9) :80-83.DOI:10.14163/j.cnki.11-5547/r.2024.09.021

分析氯沙坦联合贝那普利对肾实质性高血压患者血压水平及肾功能的影响

Analysis of the effects of losartan combined with benazepril on blood pressure and renal function in patients with renal parenchymal hypertension

蔡丽
中国实用医药2024,Vol.19Issue(9) :80-83.DOI:10.14163/j.cnki.11-5547/r.2024.09.021

分析氯沙坦联合贝那普利对肾实质性高血压患者血压水平及肾功能的影响

Analysis of the effects of losartan combined with benazepril on blood pressure and renal function in patients with renal parenchymal hypertension

蔡丽1
扫码查看

作者信息

  • 1. 274300 单县海吉亚医院内科
  • 折叠

摘要

目的 分析氯沙坦与贝那普利联合治疗对肾实质性高血压患者血压水平、肾功能的影响.方法 选取 120 例肾实质性高血压患者,按随机数字表法分为对照组及研究组,各 60 例.对照组给予贝那普利进行治疗,研究组给予氯沙坦与贝那普利联合治疗.比较两组患者治疗前后的血压(舒张压、收缩压)及肾功能指标(24 h尿蛋白定量、血肌酐)水平,不良反应发生情况.结果 治疗后,两组患者的舒张压、收缩压均低于本组治疗前,且研究组的舒张压(80.25±3.89)mm Hg(1 mm Hg=0.133 kPa)、收缩压(123.06±12.56)mm Hg比对照组的(87.87±4.93)、(131.46±10.92)mm Hg低,差异有统计学意义(P<0.05).治疗后,两组 24 h尿蛋白定量、血肌酐均低于本组治疗前,且研究组 24 h尿蛋白定量(1.23±0.08)g/24 h、血肌酐(127.13±13.62)μmol/L低于对照组的(1.52±0.14)g/24 h、(143.14±16.17)μmol/L,差异有统计学意义(P<0.05).治疗后,研究组不良反应发生率 6.67%比对照组的 21.67%低,差异有统计学意义(P<0.05).结论 氯沙坦与贝那普利联合治疗肾实质性高血压患者的效果较好,能有效改善患者的血压指标及肾功能情况,且减少不良反应,有一定临床应用与研究价值.

Abstract

Objective To analyze the effects of losartan combined with benazepril on blood pressure and renal function in patients with renal parenchymal hypertension.Methods A total of 120 patients with renal parenchymal hypertension were selected and divided into a control group and a study group according to random number table method,each with 60 cases.The control group was treated with benazepril,and the study group was treated with losartan and benazepril.The blood pressure(diastolic blood pressure,systolic blood pressure)and renal function indexes(24-h urinary protein quantity,blood creatinine)before and after treatment,and the occurrence of adverse reactions were compared between the two groups.Results After treatment,the diastolic blood pressure and systolic blood pressure in both groups were lower than those before treatment;the study group had diastolic blood pressure of(80.25±3.89)mm Hg(1 mm Hg=0.133 kPa)and systolic blood pressure of(123.06±12.56)mm Hg,which were lower than(87.87±4.93)and(131.46±10.92)mm Hg in the control group;the difference was statistically significant(P<0.05).After treatment,the 24-h urinary protein quantity and serum creatinine in both groups were lower than those before treatment;the study group had 24-h urinary protein quantity of(1.23±0.08)g/24 h and serum creatinine of(127.13±13.62)μmol/L,which were lower than(1.52±0.14)g/24 h and(143.14±16.17)μmol/L in the control group;the difference was statistically significant(P<0.05).After treatment,the incidence of adverse reactions in the study group was 6.67%,which was lower than 21.67%in the control group,and the difference was statistically significant(P<0.05).Conclusion The combination of losartan and benazepril in the treatment of patients with renal parenchymal hypertension has a good effect,which can effectively improve the blood pressure index and renal function of patients,and reduce adverse reactions.It has certain clinical application and research value.

关键词

氯沙坦/贝那普利/肾实质性高血压/血压水平/肾功能

Key words

Losartan/Benazepril/Renal parenchymal hypertension/Blood pressure level/Renal function

引用本文复制引用

出版年

2024
中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
参考文献量15
段落导航相关论文